35326711000001108: Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \UK product\Virtual medicinal product\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \UK product\Virtual therapeutic moiety\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \UK product\Virtual therapeutic moiety\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \UK product\Trade family\Herzuma\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
• \Medicinal product\Product manufactured as parenteral dose form\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-May 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
2371251000001113	Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2371261000001111	Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
106909701000001114	Herzuma 150mg powder for concentrate for solution for infusion vials (Napp Pharmaceuticals Ltd) (product)	en	Fully specified name	Inactive	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
106909801000001117	Herzuma 150mg powder for concentrate for solution for infusion vials (Napp Pharmaceuticals Ltd)	en	Synonym	Inactive	Entire term case sensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start